Search
Menu
Home
HTB
2005
September
HTB
September 2005
Contents
Editorial
Volume 6 Number 9 September 2005
Conference reports
3rd IAS Conference on HIV Pathogenesis and Treatment, 24-27 July 2005, Rio de Janeiro, Brasil
Adult male circumcision reduces transmission rates over 18 months comparable to a vaccine with 65% efficacy
Benefits of adding 4 or 7 days of AZT/3TC to single-dose nevirapine to prevent MTCT: further analysis from TOPS
New drugs in pregnancy: atazanavir; T20
Lopinavir/r use in children less than two years old promising results despite low plasma levels
Favourable outcomes in children treated with HAART in the MSF programmes
Encouraging results with cut up generic fixed dose combination tablets in Uganda
Predictors of survival at three years follow up for HIV-infected children in Cote D’Ivoire
Benefit of maintaining the M184V mutation with 3TC monotherapy: final 48-week results
T20 (enfuvirtide) studies presented at Rio
Strategies for salvage therapy
Antiviral activity of foscarnet in salvage patients
Novel strategies with existing drugs
Antiretroviral activity of new and novel agents
Overview of pharmacology studies
Incidence of TB infection despite HAART and treatment in coinfected patients
Evaluation of ESAT-6 and CFP-10 as markers for response to TB treatment in HIV/TB coinfected patients
Does WHO clinical stage reliably predict who should receive ARV treatment?
Continuous vs intermittent treatment with triple nuke combination of AZT/3TC/tenofovir in Africa: early results from DART study
Treatment access
Global Fund commitment to $175M annually in 2006, 2007
Pregnancy
US Preventative Services Task Force recommends screening all pregnant women for HIV
Guidelines
UK treatment guidelines online (2005)
Side effects
EMEA statement on metabolic and cardiovascular complications of antiretroviral therapy in HIV-infected patients
EMEA statement on use of antiretroviral treatment in HIV-patients with hepatic impairment and/or HBV/HCV co-infection
Other news
Volume 6 Number 9 September 2005 PDF
HTB RSS
Early access
Bipolar disorder in people living with HIV
31 October 2024
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
29 October 2024
Mpox breakthrough cases after two doses of the MVA-BN vaccine
29 October 2024
All early access reports
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate